Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

PASGPASG
Showing 8 of 25 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in Passage Bio, Inc.

GEODE CAPITAL MANAGEMENT, LLC holds 37,026 shares of PASG (Passage Bio, Inc.), worth $180,716 as of 2026-Q2. The position was decreased (-10.5% shares).

Current Value

$180,716

Current Shares

37,026

Total Value Change

-$176,016

Total Shares Change

-472,490

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
37,026
-10.5%
$180,7160.0%$4.88
0
2026-Q1
Increased
41,380
+31.8%
$324,8780.0%$8.00
20
2025-Q4
Increased
31,397
+15.1%
$370,5500.0%$10.70
19
2025-Q3
Decreased
27,283
-94.9%
$218,5830.0%$8.14
0
2025-Q2
Decreased
538,578
-1.4%
$215,6340.0%$6.62
0
2025-Q1
Increased
546,101
+2.7%
$192,8720.0%$7.62
16
2024-Q4
Increased
531,565
+4.3%
$301,5210.0%$13.30
17
2024-Q3
Increased
509,516
+18.2%
$356,7320.0%$13.68
19

Other major holders of PASG: ALKEON CAPITAL MANAGEMENT LLC, Woodline Partners LP, CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used